API

Active Pharmaceutical Ingredients (API), popularly speaking, are the raw materials of medicines, only pharmaceutical raw materials are processed into pharmaceutical preparations , can they become medicines available for clinical use, so drugs we usually eat are the finished drugs through processing. Active Pharmaceutical Ingredients based on its sources can be divided into two major categories ,including chemical synthetic drugs and natural chemical drugs. Chemical synthetic drugs can be divided into organic synthetic drugs and inorganic synthetic drugs. Inorganic synthetic drugs are inorganic compounds ( very few is element), such as aluminum hydroxide, magnesium trisilicate which are used for the treatment of gastric and duodenal ulcers ; organic synthetic drugs are mainly composed of drugs made by basic organic chemical raw materials, through a series of organic chemical reactions (such as aspirin, chloramphenicol, caffeine, etc.). Natural chemical drugs ,based on its sources,can be divided into two categories including biochemical drugs and plant chemical drugs. Antibiotics are generally made by the microbial fermentation, which belongs to the biochemistry category. A variety of semi-synthetic antibiotics occurs in recent years,which are biosynthesis and chemical synthesis combining products.Among active Pharmaceutical Ingredients, the organic synthetic drugs varieties, yields and values have the largest proportion,which are the main pillars of the chemical and pharmaceutical industries. The quality of active Pharmaceutical Ingredients decides whether the formulation is good or bad , so its quality standards are very strict ,countries in the world have developed national pharmacopoeia standards and strict quality control methods for its widely used active Pharmaceutical ingredients.

p-Toluenesulfonyl Isocyanate: Environmental Fate,Reagent and Impact on LIB Electrolyte

p-Toluenesulfonyl isocyanate hydrolyzes rapidly, acts as a fast derivatization reagent for hydroxyls, and improves LIB electrolyte stability.

Sep 2,2025  API

2',5'-Dihydroxyacetophenone: Hypouricemic, Anti-Melanogenic, and Anti-Multiple Myeloma Properties

2',5'-Dihydroxyacetophenone lowers uric acid, inhibits melanin, induces multiple myeloma cell apoptosis via key pathways.

Sep 1,2025  API

3-Chloropropyne: Physical Properties and Dissociative Adsorption Mechanism on Si(111)-(7 × 7) Surface

3-Chloropropyne, a volatile colorless-to-yellow liquid, adsorbs on Si(111)-(7×7) via C–Cl bond cleavage, with preserved ethynyl for further functionalization.

Aug 29,2025  API

Chondroitin 4-Sulfate: From Osteoarthritis Research to Immunomodulatory Roles and Safety Considerations

Chondroitin 4-sulfate, a glycosaminoglycan,has immunomodulatory effects, and requires more standardized trials for clear safety-efficacy data.

Aug 29,2025  API

(-)-Di-p-toluoyl-L-tartaric Acid: Chiral Extraction and Hydrogenation Applications

(-)-Di-p-toluoyl-L-tartaric acid aids mandelic acid chiral extraction, forms luminescent/magnetic Ln-complexes,and boosts asymmetric hydrogenation.

Aug 28,2025  API

Osimertinib Mesylate: Efficacy in EGFR-Mutant NSCLC, Clinical Applications, and Resistance Mechanisms

Osimertinib mesylate treats EGFR-mutant NSCLC, shows good efficacy/PFS, targets CNS mets, but faces C797S/MET resistance.

Aug 27,2025  API

Eltrombopag Olamine in Thrombocytopenia Treatment

Eltrombopag olamine (TPO-R agonist) treats ITP-related thrombocytopenia (adults/≥1y kids), with bioequivalence studies in Chinese.

Aug 26,2025  API

Ethyl Linoleate (LA-EE): Structural and Physicochemical Background for Dermatological and Cosmeceutical Research

Ethyl linoleate has supporting applications in skin care and inflammation control.

Aug 26,2025  API

4-Chlororesorcinol: From Cosmetic Use to Environmental Degradation Studies

4-Chlororesorcinol has practical applications in chemical industry and environment research

Aug 25,2025  API

The Therapeutic Potential of 2′-Deoxycytidine

2′-Deoxycytidine has tremendous potential in medical applications.

Aug 22,2025  API
Prev12345678910...Next>  Go to Page